MAPK3 and cancer: To the best of our knowledge, this is the first report on monitoring of chemotherapy induced activation of pro-survival ERK1/2 and AKT arm in cancer cells derived from malignant ascites by BRET technology, which may offer unique application of these sensors in clinical sectors to foresee efficacy of chemotherapeutics.